SCHEMBL21369879

SCHEMBL21369879

c1ccc(-c2cc(-c3ccccc3)cc(-c3cc(-c4ccccc4)nc(-c4cc(-c5cc6ccccc6c6ccccc56)cc(-n5c6ccccc6c6ccccc65)c4)n3)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.38
KDM4E B2RXH2 5/20 0.36
L3MBTL1 Q9Y468 4/20 0.36
ATM Q13315 1/20 0.36
MEN1 O00255 5/20 0.35
KMT2A Q03164 5/20 0.35
ALDH1A1 P00352 5/20 0.35
HPGD P15428 5/20 0.35
MAPT P10636 4/20 0.35
NTSR1 P30989 1/20 0.35
HTR6 P50406 2/20 0.34
MAPK1 P28482 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
LMNA P02545 1/20 0.33
ADORA2A P29274 2/20 0.33
ADORA1 P30542 2/20 0.33
ACACA Q13085 1/20 0.32
ALOX5 P09917 1/20 0.32
MPI P34949 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21369800 0.96 CYP11B1 (0.39) CYP11B1KDM4EL3MBTL1ATMMEN1
SCHEMBL21370365 0.96 CYP11B1 (0.39) CYP11B1KDM4EL3MBTL1ATMMEN1
SCHEMBL21369799 0.96 CYP11B1 (0.40) CYP11B1KDM4EL3MBTL1ATMMEN1
SCHEMBL21369773 0.95 MEN1 (0.40) CYP11B1KDM4EL3MBTL1ATMMEN1
SCHEMBL21369672 0.95 MEN1 (0.40) CYP11B1KDM4EL3MBTL1ATMMEN1
SCHEMBL21369671 0.95 CYP11B1 (0.40) CYP11B1KDM4EL3MBTL1ATMMEN1
SCHEMBL21370319 0.94 CYP11B1 (0.34) CYP11B1KDM4EL3MBTL1ATMMEN1
SCHEMBL21369801 0.94 KDM4E (0.38) CYP11B1KDM4EL3MBTL1ATMMEN1
SCHEMBL21369880 0.94 CYP11B1 (0.39) CYP11B1KDM4EL3MBTL1ATMMEN1
SCHEMBL21369900 0.93 CYP11B1 (0.40) CYP11B1KDM4EL3MBTL1ATMMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190288215-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME SOULBRAIN CO., LTD. (KR) 2019-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190288215-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, CYP1B1 CYP11B1 37/4885KDM4E 2473/4885L3MBTL1 1787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.